Alginate and Innohep drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Alginate (algin) and Innohep (tinzaparin sodium). Common drug interactions include diarrhoea among females and febrile neutropenia among males.

The phase IV clinical study analyzes what interactions people have when they take Alginate and Innohep. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Alginate?

Alginate has active ingredients of algin. eHealthMe is studying from 1,556 Alginate users. Check the latest studies of Alginate.

What is Innohep?

Innohep has active ingredients of tinzaparin sodium. eHealthMe is studying from 9,243 Innohep users. Check the latest studies of Innohep.

On Jul, 14, 2026

17 people who take Alginate and Innohep together, and have interactions are studied.

What are the common drug interactions of Alginate and Innohep, by gender? *:

female:

Diarrhoea
Dyspnoea (difficult or laboured respiration)
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
Lung disorder (lung disease)
Cardiac failure
Ear haemorrhage (bleeding from ear)
Hepatosplenomegaly (enlargement of both the liver and the spleen)
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection)
Leukocytosis (increased white blood cells)
Renal failure (kidney dysfunction)

male:

Febrile neutropenia (fever with reduced white blood cells)
Sepsis (a severe blood infection that can lead to organ failure and death)
Arthralgia (joint pain)
Hyperthermia (body temperature greatly above normal)
Hypertrophic osteoarthropathy (syndrome of clubbing of the digits, periostitis of the long (tubular) bones, and arthritis)
Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)

What are the common drug interactions of Alginate and Innohep, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Arthralgia (joint pain)
Hypertrophic osteoarthropathy (syndrome of clubbing of the digits, periostitis of the long (tubular) bones, and arthritis)

40-49:

n/a

50-59:

Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon)
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Oxygen saturation decreased
Abdominal pain

60+:

Neutropenia (an abnormally low number of neutrophils)
Hyperuricaemia (level of uric acid in the blood that is abnormally high)
Hepatosplenomegaly (enlargement of both the liver and the spleen)
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection)
Leukocytosis (increased white blood cells)
Renal failure (kidney dysfunction)
Respiratory failure (inadequate gas exchange by the respiratory system)
Thrombocytopenia (decrease of platelets in blood)
Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)
Weight increased

What are the existing conditions these people have? *

Insomnia (sleeplessness): 10 people, 58.82%
Allergies: 9 people, 52.94%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 9 people, 52.94%
High Blood Pressure: 8 people, 47.06%
Diarrhea: 8 people, 47.06%
Arrhythmias (irregular heartbeat): 8 people, 47.06%
Hypovitaminosis (any of several diseases caused by deficiency of one or more vitamins): 8 people, 47.06%
Infection: 8 people, 47.06%
Calcium Deficiency (lack of calcium): 8 people, 47.06%
Stress And Anxiety: 7 people, 41.18%

* Approximation only. Some reports may have incomplete information.

Do you take Alginate and Innohep?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously